BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 10430264)

  • 1. Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study.
    Katagiri H; Takahashi M; Inagaki J; Sugiura H; Ito S; Iwata H
    Cancer; 1999 Aug; 86(3):533-7. PubMed ID: 10430264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer of unknown primary site.
    Gallagher CJ; Reznek RH
    Clin Med (Lond); 2008 Aug; 8(4):451-4. PubMed ID: 18724619
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigations for bone metastasis from an unknown primary.
    Destombe C; Botton E; Le Gal G; Roudaut A; Jousse-Joulin S; Devauchelle-Pensec V; Saraux A
    Joint Bone Spine; 2007 Jan; 74(1):85-9. PubMed ID: 17218141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective examination methods for identifying the primary origins of metastatic bone tumors of unknown primary origin during the initial visit: A retrospective chart review study.
    Fujibuchi T; Imai H; Kidani T; Miura H
    SAGE Open Med; 2022; 10():20503121221097582. PubMed ID: 35646367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data independent acquisition-mass spectrometry (DIA-MS)-based comprehensive profiling of bone metastatic cancers revealed molecular fingerprints to assist clinical classifications for bone metastasis of unknown primary (BMUP).
    Ku X; Cai C; Xu Y; Chen S; Zhou Z; Xiao J; Yan W
    Transl Cancer Res; 2020 Apr; 9(4):2390-2401. PubMed ID: 35117599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Surgical Management of Proximal Femoral Metastases: A Narrative Review.
    Axelrod D; Gazendam AM; Ghert M
    Curr Oncol; 2021 Sep; 28(5):3748-3757. PubMed ID: 34677238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of Spinal Metastases: A Retrospective View.
    Başdelioğlu K
    Int J Spine Surg; 2021 Feb; 15(1):119-129. PubMed ID: 33900965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of occult solid malignancy in patients with polymyalgia rheumatica-like symptoms.
    Ramon A; Guillibert-Karras C; Milas-Julien L; Garrot JF; Maillefert JF; Ornetti P
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X20984275. PubMed ID: 33552239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?
    Lawrenz JM; Gordon J; George J; Haben C; Rubin BP; Ilaslan H; Mesko NW; Nystrom LM
    Clin Orthop Relat Res; 2020 Nov; 478(11):2451-2457. PubMed ID: 33112582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site.
    Yoo SW; Chowdhury MSA; Jeon S; Kang SR; Lee C; Jabin Z; Kim J; Cho SG; Song HC; Bom HS; Min JJ; Kwon SY
    Nucl Med Mol Imaging; 2020 Aug; 54(4):192-198. PubMed ID: 32831965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical bone pain revealing a bone metastatic colon cancer: A case report.
    Alshatti Y; Alqallaf S; Allaham W; Granier S; Hammel P; Culine S; Lamuraglia M
    Mol Clin Oncol; 2020 Sep; 13(3):2. PubMed ID: 32754316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview.
    Argentiero A; Solimando AG; Brunetti O; Calabrese A; Pantano F; Iuliani M; Santini D; Silvestris N; Vacca A
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31470608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and risk factors in patients with metastatic bone disease of an upper extremity.
    Wisanuyotin T; Sirichativapee W; Sumnanoont C; Paholpak P; Laupattarakasem P; Sukhonthamarn K; Kosuwon W
    J Bone Oncol; 2018 Nov; 13():71-75. PubMed ID: 30591860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.
    Park SB; Park JM; Moon SH; Cho YS; Sun JM; Kim BT; Lee KH
    PLoS One; 2018; 13(5):e0196808. PubMed ID: 29746513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.
    Takagi T; Katagiri H; Kim Y; Suehara Y; Kubota D; Akaike K; Ishii M; Mukaihara K; Okubo T; Murata H; Takahashi M; Kaneko K; Saito T
    PLoS One; 2015; 10(6):e0129428. PubMed ID: 26115010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metastases of unknown origin: epidemiology and principles of management.
    Piccioli A; Maccauro G; Spinelli MS; Biagini R; Rossi B
    J Orthop Traumatol; 2015 Jun; 16(2):81-6. PubMed ID: 25726410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic bone tumors: Analysis of factors affecting prognosis and efficacy of CT and
    Shimada H; Setoguchi T; Yokouchi M; Sasaki H; Ishidou Y; Kawamura I; Abematsu M; Nagano S; Komiya S
    Mol Clin Oncol; 2014 Sep; 2(5):875-881. PubMed ID: 25054061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-spine bone metastasis as an initial manifestation of cancer in Korea.
    Kim W; Han I; Kang S; Lee SA; Kim HS
    J Korean Med Sci; 2014 Mar; 29(3):357-62. PubMed ID: 24616584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging findings of solitary spinal bony lesions and the differential diagnosis of benign and malignant lesions.
    Kim YS; Han IH; Lee IS; Lee JS; Choi BK
    J Korean Neurosurg Soc; 2012 Aug; 52(2):126-32. PubMed ID: 23091671
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.